JNJ vs. MU: Johnson & Johnson vs. Micron Stock Comparison

Company Profile

Johnson & Johnson (JNJ) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Micron (MU) belongs to Information Technology (Semiconductors & Semiconductor Equipment) — their GICS classifications point to very different parts of the market.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Micron (MU) has a highly aggressive beta of 2.44, indicating much higher sensitivity to broad-market moves, while Johnson & Johnson (JNJ) is defensive at 0.21 and tends to be less market-sensitive — a wide gap in beta profiles.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both companies show strong equity returns, but Micron (MU) at 88.26% is the standout with ROE above its industry range; Johnson & Johnson (JNJ) at 20.02% also sits in the top quartile.

For every dollar of sales, both Johnson & Johnson (JNJ) at 16.20% and Micron (MU) at 63.80% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Micron (MU) at 80.68% shows unusually strong operating efficiency — above its industry’s operating margin range — and Johnson & Johnson (JNJ) at 25.74% also operates in the top quartile.

Profitability Metrics

Growth

Micron (MU) at 256.33% clears its industry range for revenue growth, far stronger top-line momentum than Johnson & Johnson (JNJ) at 6.05%, which is closer to a typical peer reading.

Both companies show strong earnings momentum, but Micron (MU) at 879.31% is the standout with EPS growth above its industry range; Johnson & Johnson (JNJ) at 90.50% also sits in the top quartile.

Growth Metrics

Financial Strength

Micron (MU) at 3.31 keeps current ratio within its industry’s typical mid-range, while Johnson & Johnson (JNJ) at 1.02 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for JNJ.

Micron (MU) at 0.04 keeps leverage in the lower industry quartile, while Johnson & Johnson (JNJ) at 0.55 runs a more typical debt-to-equity mix.

Financial Strength Metrics

Dividends

Micron (MU) at 0.09% pays an industry-typical yield; Johnson & Johnson (JNJ) at 1.94% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.

Micron (MU) at 0.71% keeps its payout in the industry’s typical band, while Johnson & Johnson (JNJ) at 80.12% pays out more than any of its peers — the most stretched cover in its group.

Dividend Metrics

Valuation

Micron (MU) at 9.28 sits in the cheaper P/E ratio quartile, while Johnson & Johnson (JNJ) at 41.92 is closer to its industry’s usual earnings multiple — a discount for MU, though growth and earnings durability still matter.

On P/S ratio, both Johnson & Johnson (JNJ) at 6.69 and Micron (MU) at 5.86 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

Micron (MU) at 5.64 is valued about in line with its industry on P/B ratio, while Johnson & Johnson (JNJ) at 8.16 carries an above-peer premium to book — JNJ is pricier on assets.

Valuation Metrics